🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study to investigate the relative bioavailability of BIBR 953 ZW after admi...
Status
Completed
Location
Multiple Locations
Start Date
2003-08
Trial ID
NCT02170597
Treatments Being Tested
Study to investigate and compare safety, pharmacokinetics and pharmacodynam...
Status
Completed
Location
Multiple Locations
Start Date
2004-12
Trial ID
NCT02170909
Treatments Being Tested
To assess the extent of absorption of 12.5, 50 and 200 mg of BIBR 1048 MS w...
Status
Completed
Location
Multiple Locations
Start Date
2001-02
Trial ID
NCT02170792
Treatments Being Tested
Vitamin K antagonists were hampered by several disadvantages, such as the n...
Status
Completed
Location
CHU Besancon
Start Date
2014-11-13
Trial ID
NCT02103101
To assess safety, pharmacokinetics and the effect of BIBR 1048 MS on coagul...
Status
Completed
Location
Multiple Locations
Start Date
1999-05
Trial ID
NCT02170831
Comparative pharmacokinetics of BIBR 1048 MS solution and tablet with or wi...
Status
Completed
Location
Multiple Locations
Start Date
1999-07
Trial ID
NCT02170922
Treatments Being Tested
To assess safety, pharmacokinetics and the effect of BIBR 1048 MS on coagul...
Status
Completed
Location
Multiple Locations
Start Date
1999-11
Trial ID
NCT02170740
Treatments Being Tested
To assess the extend of absorption of 12.5, 25, 50 and 100 mg of BIBR 1048 ...
Status
Completed
Location
Multiple Locations
Start Date
2000-10
Trial ID
NCT02170766
Treatments Being Tested